Liver & Intestine Transplant Journal Articles

 
 
  • The Impact of DAAs on Transplant Costs and Outcomes A new study provides insight into the costs of HCV treatment in liver and kidney transplant recipients and the impact of these agents on longer-term transplant outcomes.
  • Liver Fat Scores Predict Liver Disease Mortality in the US This study examined how markers of liver health are associated with mortality in persons without viral hepatitis in the United States. Are liver fat scores useful for metabolic health surveillance?
  • Drug-induced Liver Injury in the Context of NAFLD How might certain drugs be more hepatotoxic in NAFLD patients? This article explores the pathophysiological mechanisms and reciprocity involved in NAFLD and drug-induced steatohepatitis.
  • Hospitalization Costs for High-Need Patients With GI Diseases This study analyzed the annual burden and costs of hospitalization in patients with chronic GI and liver disease. Which patients are at high risk for frequent hospitalizations and long hospital stays?
  • The Misunderstood Coagulopathy of Liver Disease An elevated INR is commonly considered an indication of bleeding risk in patients with liver disease, but is this practice supported by the evidence?
  • DTI + MRS to Predict Neurological Outcome Before TIPSS How might multimodal MRI imaging be used to determine patients at risk of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt placement?
  • Profile, Risk Factors and Outcome of AKI in Pediatric ACLF This study aimed to identify risk factors for and describe the natural course, presentation, and outcome of acute kidney injury in pediatric patients with acute-on-chronic liver failure.
  • HCV-Infected Kidney Waitlist Patients: Treat Now or Later? Which factors should be considered in the decision to initiate early or deferred direct-acting antiviral therapy among HCV-positive waitlisted patients?
  • Transplants From HBV+ Donors: Is It Safe? Is It Ethical? Should prior exposure to HBV make a liver donor ineligible? This review explores the safety and ethical considerations surrounding the transplantation of anti-HBc+ donor livers.
  • Preconception Management of Thyroid Dysfunction Effectively managing maternal thyroid disorders during the preconception period is key to ensuring optimal pregnancy outcomes.
  • Systemic Treatment of Hepatocellular Carcinoma This review discusses the evolution of targeted therapy with tyrosine kinase inhibitors and recent developments in immunotherapy for systemic treatment of hepatocellular carcinoma.
  • Novel and Emerging Therapies for Cholestatic Liver Diseases A better understanding of the pathophysiology of cholestatic liver diseases has led to the development of more targeted treatment options. Find out what's new.
  • Toxoplasmosis in Transplant Recipients Transplant recipients are at a greater risk for developing toxoplasmosis. Are these patients being adequately screened and treated?
  • Hepatic Steatosis Across the Pediatric Age Spectrum Is fatty liver disease more common in young children than previously thought? Using abdominal CT, this study investigated the prevalence of hepatic steatosis in a cohort of healthy children.
  • Feasibility and Cost-effectiveness of Reaching WHO HCV Targets This study evaluated the success and cost-effectiveness of initiatives to increase HCV treatment uptake and interventions for reducing the incidence of new infection among injection drug users.
  • Effects of Biologics on Biliary Inflammation in PSC and IBD Are the biological therapies used for the treatment of inflammatory bowel disease effective for the treatment of primary sclerosing cholangitis in patients with concomitant IBD?
  • Postpartum Acute Fatty Liver of Pregnancy Acute fatty liver of pregnancy can pose significant risk of mortality to healthy women, and as this case demonstrates, the clinical presentation can be highly variable and nonspecific.
  • Timing of HCV Therapy in Liver Transplant-Eligible Patients The authors developed a decision tree model to compare the cost-effectiveness of three strategies for timing of DAA treatment for HCV in liver transplant candidates.
  • Pediatric LT and Transition to Adult Healthcare Service This study examined the outcome of liver transplant recipients after their transition from pediatric to adult healthcare services. How common was non-adherence, and what were the contributing factors?
  • C. diff Infection and Graft Loss in Solid Organ Transplants The development of C. difficile infection following solid organ transplantation may contribute to an increased risk of graft loss, a new study suggests.
www.pharmacy24.com.ua

https://viagraon.com

http://cialis-viagra.com.ua